NCT00592124View on ClinicalTrials.gov

Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women

PHASE2CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
HIV Infections
Interventions
DRUG

Tenofovir disoproxil fumarate

300 mg tablet daily

DRUG

Tenofovir gel

1 gm/100 ml of 1% gel vaginally daily

Trial Locations (7)

35294

Alabama Microbicide CRS, Birmingham

44106

Case CRS, Cleveland

Unknown

Bronx- Lebanon Hospital Center Clinical Research Site (BLHC CRS), The Bronx

Botha's Hill CRS, Durban

Umkomaas CRS, Durban

Makerere University- JHU Research Collaboration {MUJHU CARE LTD} CRS, Kampala

15213-2582

Pitt CRS, Pittsburgh

Sponsors
All Listed Sponsors
collaborator

Microbicide Trials Network

NETWORK

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH